|
KMID : 0882420180930060571
|
|
Korean Journal of Medicine
2018 Volume.93 No. 6 p.571 ~ p.574
|
|
|
Pneumocystis Pneumonia Developing during Treatment of Recurrent Renal Cell Cancer with Nivolumab
|
|
Kim Hak-Ro
Keam Bhum-Suk
Park Young-Sik
Kim Mi-So
Kim Tae-Min
Kim Dong-Wan
Heo Dae-Seog
|
|
|
Abstract
|
|
|
|
Nivolumab is an immune checkpoint inhibitor approved for the treatment of metastatic cancers. Here, we report the case of a 65-year-old male with recurrent renal cell carcinoma. After six cycles of nivolumab treatment, positron emission tomography/computed tomography (PET/CT) was performed to evaluate the response. PET/CT revealed diffuse ground glass opacities in both lungs. He developed a cough, sputum, chills, and a febrile sense. After bronchoscopic bronchoalveolar lavage, pneumocystis pneumonia was finally diagnosed.
|
|
|
KEYWORD
|
|
|
Nivolumab, Pneumonia, Pneumocystis pneumonia
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|